info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Buergers Disease Companies

Buerger's disease companies specialize in addressing thromboangiitis obliterans, also known as Buerger's disease, a condition characterized by inflammation and blockage of small and medium-sized blood vessels, typically in the limbs. These companies contribute to vascular health by providing medical interventions, medications, and lifestyle management strategies to address and alleviate symptoms associated with Buerger's disease.

Buerger

 


Latest Buerger’s disease Companies Updates:


Jan 2024


STEMPEUTICS RESEARCH PVT LTD Received renewed approval from the Indian regulatory authorities for the commercialization of their Stempeucel, a stem cell-based therapy for BD.Conducted clinical trials on Stempeucel's efficacy and safety in BD patients, with promising results showing improved blood flow and pain relief.


t2cure GmbH Completed Phase II clinical trials for their novel anti-platelet aggregation drug candidate for BD, demonstrating positive effects on limb perfusion and symptom improvement.Partnered with academic institutions to investigate the underlying mechanisms of BD and identify potential new therapeutic targets.


Fujifilm Holdings Corporation Introduced their latest angiography system with improved image resolution and faster scan times, facilitating accurate diagnosis of vascular blockages associated with BD.Collaborated with healthcare providers to implement their system in BD diagnosis and treatment protocols.


Shimadzu Corporation Developed a portable non-invasive vascular assessment device for early detection of peripheral arterial disease, a major risk factor for BD.Focused on expanding their product portfolio for early diagnosis and monitoring of BD progression.


The Buerger's Disease Foundation Launched a new awareness campaign highlighting the early symptoms and importance of timely diagnosis for managing BD effectively.Funded research grants for BD research and patient advocacy initiatives.


List of Buerger’s disease Key companies in the market



  • FUJIFILM Holdings Corporation (Japan)

  • General Electric Company (US)

  • Koninklijke Philips N.V. (the Netherlands)

  • Pluristem (Israel)

  • Shimadzu Corporation (Japan)

  • Siemens Healthcare GmbH (Germany)

  • STEMPEUTICS RESEARCH PVT LTD (India)

  • Toshiba Medical Corporation (Japan)

  • t2cure GmbH (Germany)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.